All Articles

Browse all articles — filter by topic, how strong the science is, or date.

Showing 505–528 of 767 in Treatments & Drugs

Apr 28, 2026globenewswire.com

Are You Aware of This Hidden Heart Condition?

generalTreatments & Drugsclinical

Apr 28, 2026globenewswire.com

"New Test Improves Detection of Brain Cancer Cells"

generalTreatments & Drugsclinical

Apr 28, 2026longevity.technology

Can a new drug help manage inflammation for better aging?

significantTreatments & Drugssmall human trial

Apr 28, 2026globenewswire.com

Can gut health improve cancer treatment outcomes?

generalTreatments & Drugssmall human trial

Apr 28, 2026longevity.technology

Could a new injection improve diabetes management?

significantTreatments & Drugsclinical

Apr 28, 2026globenewswire.com

Boehringer Ingelheim’s novel glucagon/GLP-1 dual agonist survodutide achieved significant weight loss of 16.6% delivering meaningful metabolic improvement in people with obesity or overweight in Phase III trial

generalTreatments & Drugs

Apr 28, 2026sciencedaily.com

Could a new enzyme make Ozempic work better for you?

generalTreatments & Drugssmall human trial

Apr 27, 2026globenewswire.com

Biomea Fusion Announces Positive 52-Week Results from Phase 2 COVALENT-112 Trial in Type 1 Diabetes Showing C-Peptide Improvement and Durability Following 12-Weeks of Icovamenib Treatment

generalTreatments & Drugs

Apr 27, 2026globenewswire.com

Umoja Biopharma Announces Unveiling of UB-VV500 in Upcoming Poster Presentation at the American Society of Gene & Cell Therapy Annual Meeting

generalTreatments & Drugs

Apr 27, 2026globenewswire.com

Aegis Treatment Centers Opens Medication Unit in Crescent City, Expanding Access to Addiction Treatment in Del Norte County

generalTreatments & Drugs

Apr 27, 2026lifespan.io

A Robust Senescence Response Helps Wounds Heal

significantTreatments & Drugs

Apr 27, 2026globenewswire.com

Adial Pharmaceuticals Submits Application to FDA Commissioner’s National Priority Voucher (CNPV) Pilot Program for AD04 Clinical Development Program

generalTreatments & Drugs

Apr 27, 2026globenewswire.com

Cardiff Oncology to Host Key Opinion Leader Discussion on Onvansertib’s Promising Single-Agent Activity

generalTreatments & Drugs

Apr 27, 2026globenewswire.com

Ocular Therapeutix™ to Participate in May Scientific and Investor Conferences

generalTreatments & Drugs

Apr 27, 2026investor.lilly.com

New Hope for Blood Cancer Patients: A Promising Treatment

significantTreatments & Drugssmall human trial

Apr 27, 2026globenewswire.com

Relay Therapeutics Announces Clinical Data for Zovegalisib plus Atirmociclib Triplet Combination Supportive of Further Development in Frontline Metastatic Breast Cancer

generalTreatments & Drugs

Apr 27, 2026longevity.technology

Calluna completes enrollment in Phase 2 AURORA study

significantTreatments & Drugs

Apr 27, 2026longevity.technology

Nuritas brings PeptiStrong clinical momentum to Vitafoods

significantTreatments & Drugs

Apr 26, 2026fightaging.org

Fight Aging! Newsletter, April 27th 2026

generalTreatments & Drugs

Apr 24, 2026globenewswire.com

FDA Accelerates Action on Treatments for Serious Mental Illness Following Executive Order

generalTreatments & Drugs

Apr 24, 2026globenewswire.com

Indivior Presents New Real-World Data at ASAM 2026 Annual Conference, Supporting Remission as a Treatment Outcome and Reinforcing the Clinical Benefits of Monthly Injectable Buprenorphine for Opioid Use Disorder

generalTreatments & Drugs

Apr 24, 2026fightaging.org

Dasatinib and Quercetin Outperform Navitoclax in a Mouse Model of Intervertebral Disc Degeneration

noteworthyTreatments & Drugs

Apr 24, 2026globenewswire.com

Levicept to Present Data from Phase II study of LEVI-04 at OARSI 2026 World Congress on Osteoarthritis

generalTreatments & Drugs

Apr 24, 2026longevity.technology

Springfield Wellness Center marks 25 years of NAD+ IV therapy

significantTreatments & Drugs